You are here:

Tools Content :

 

Press Releases

Sanofi Pasteur Receives Governor’s Award for Environmental Excellence

Swiftwater site project hailed for environmental protection and responsible economic development benefits

Apr 22, 2009

Harrisburg, Pa. - April 22, 2009 -- This evening, sanofi pasteur, the vaccines division of the sanofi-aventis Group, will be recognized as one of the recipients of the 2009 Governor’s Awards for Environmental Excellence. Sanofi Pasteur was selected from 40 applicants based on the company’s leadership and innovation in constructing its on-site wastewater treatment plant and spray irrigation expansion project, which was completed last summer.

 

The award demonstrates the company’s commitment to environmental preservation, energy reduction and responsible economic development. By providing vital infrastructure to the Swiftwater facility using state-of-the-industry technologies, along with land preservation and conservation activities, the project enables the company to continue and expand its mission as the nation’s premier researcher, developer, manufacturer, and supplier of vaccines for the protection of human health in the United States and the world.

 

Sanofi Pasteur US President and Vice President of the Americas Damian Braga said, “This highly coveted award reinforces our company’s commitment to Corporate Social Responsibility, environmental stewardship, and responsible site growth here in the Commonwealth.” According to Braga, the completion of the project is critical to the company’s continued expansion in Swiftwater.

 

The sanofi pasteur wastewater treatment and irrigation initiative is the only one of its kind in Northeast Pennsylvania, and one of the few in the Commonwealth.

 

The project provides several environmental benefits, including: watershed stewardship, wetlands protection, protection of Nature Conservancy deed restricted property, and savings of up to 30.6 million gallons of potable water per year by reuse of treated effluent for seasonal landscape irrigation and central utilities operations.

 

In addition to environmental stewardship, the project demonstrates economic benefit by providing the infrastructure that will enable growth and expansion of the Swiftwater facility, which would provide significant positive impact to the local community and region.

 

To obtain the permits necessary to complete these award-winning projects, sanofi pasteur worked closely with more than a half-dozen government officials and community partners, including the Delaware River Basin Commission (DRBC), Pennsylvania Department of Environmental Protection (PADEP), the Monroe County

Conservation District and Pocono Township.

 

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

 

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2008, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us

 

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans” and similar expressions. Although sanofi- aventis’ management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in sanofiaventis’ annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements. 

For further information: US Media Relations Ellyn Schindler T. +1-570-957-2689 ellyn.schindler@sanofipasteur.com www.sanofipasteur.us